Status:
UNKNOWN
The Role of Somatostatin in the Hemodynamics of the Hepatic Circulation in Patients Undergoing Liver Resection
Lead Sponsor:
Laikο General Hospital, Athens
Conditions:
Portal Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of the present clinical trial is to study the effect of somatostatin in the regulation of velocity and blood flow of the hepatic circulation in patients undergoing liver resection. The pat...
Detailed Description
The purpose of the present clinical trial is to study the effect of somatostatin in the regulation of blood flow of the portal circulation at patients who have undergone hepatectomy. The patients will...
Eligibility Criteria
Inclusion
- Patients undergoing hepatectomy for any reason including primary malignant liver tumors (hepatocellular carcinomas, cholangiocellular carcinomas, etc), metastatic liver disease and symptomatic benign liver lesions (liver adenomas, focal nodular hyperplasia, hemangiomas, etc).
- Adult patients (≥18 years old)
- Patients whose indication for hepatectomy will be decided by a multidisciplinary team meeting.
- Patients who eill agree to sign an informed consent
Exclusion
- Patients who do not meet the inclusion criteria and those
- Patients undergoing synchronous hepatectomy-colectomy.
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04010669
Start Date
August 1 2019
End Date
July 31 2020
Last Update
July 8 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.